218 related articles for article (PubMed ID: 27170216)
1. A review of interventions to reduce inter-observer variability in volume delineation in radiation oncology.
Vinod SK; Min M; Jameson MG; Holloway LC
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):393-406. PubMed ID: 27170216
[TBL] [Abstract][Full Text] [Related]
2. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
3. Uncertainties in volume delineation in radiation oncology: A systematic review and recommendations for future studies.
Vinod SK; Jameson MG; Min M; Holloway LC
Radiother Oncol; 2016 Nov; 121(2):169-179. PubMed ID: 27729166
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging organ at risk delineation for nasopharyngeal radiotherapy: Measuring the effectiveness of an educational intervention.
Ryan O; Dundas K; Surjan Y; Elwadia D; Nguyen K; Cardoso M; Kumar S
J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):59-69. PubMed ID: 36751021
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous
Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
[TBL] [Abstract][Full Text] [Related]
6. Interobserver Variability in the Delineation of Gross Tumour Volume and Specified Organs-at-risk During IMRT for Head and Neck Cancers and the Impact of FDG-PET/CT on Such Variability at the Primary Site.
Gudi S; Ghosh-Laskar S; Agarwal JP; Chaudhari S; Rangarajan V; Nojin Paul S; Upreti R; Murthy V; Budrukkar A; Gupta T
J Med Imaging Radiat Sci; 2017 Jun; 48(2):184-192. PubMed ID: 31047367
[TBL] [Abstract][Full Text] [Related]
7. Influence of inter-observer delineation variability on radiomics stability in different tumor sites.
Pavic M; Bogowicz M; Würms X; Glatz S; Finazzi T; Riesterer O; Roesch J; Rudofsky L; Friess M; Veit-Haibach P; Huellner M; Opitz I; Weder W; Frauenfelder T; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2018 Aug; 57(8):1070-1074. PubMed ID: 29513054
[TBL] [Abstract][Full Text] [Related]
8. A rapid review of influential factors and appraised solutions on organ delineation uncertainties reduction in radiotherapy.
Sadeghi S; Siavashpour Z; Vafaei Sadr A; Farzin M; Sharp R; Gholami S
Biomed Phys Eng Express; 2021 Jul; 7(5):. PubMed ID: 34265746
[No Abstract] [Full Text] [Related]
9. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
Greco C; Rosenzweig K; Cascini GL; Tamburrini O
Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
[TBL] [Abstract][Full Text] [Related]
10. Reduction of inter-observer contouring variability in daily clinical practice through a retrospective, evidence-based intervention.
Patrick HM; Souhami L; Kildea J
Acta Oncol; 2021 Feb; 60(2):229-236. PubMed ID: 32988249
[TBL] [Abstract][Full Text] [Related]
11. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
[TBL] [Abstract][Full Text] [Related]
12. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
[TBL] [Abstract][Full Text] [Related]
13. Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging.
Krengli M; Cannillo B; Turri L; Bagnasacco P; Berretta L; Ferrara T; Galliano M; Gribaudo S; Melano A; Munoz F; Sciacero P; Tseroni V; Bassi MC; Brambilla M; Inglese E
Technol Cancer Res Treat; 2010 Aug; 9(4):393-8. PubMed ID: 20626204
[TBL] [Abstract][Full Text] [Related]
14. Interobserver variability in organ at risk delineation in head and neck cancer.
van der Veen J; Gulyban A; Willems S; Maes F; Nuyts S
Radiat Oncol; 2021 Jun; 16(1):120. PubMed ID: 34183040
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
Barkati M; Simard D; Taussky D; Delouya G
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
[TBL] [Abstract][Full Text] [Related]
16. Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era.
Louie AV; Rodrigues G; Olsthoorn J; Palma D; Yu E; Yaremko B; Ahmad B; Aivas I; Gaede S
Radiother Oncol; 2010 May; 95(2):166-71. PubMed ID: 20122749
[TBL] [Abstract][Full Text] [Related]
17. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578
[TBL] [Abstract][Full Text] [Related]
18. Impact of FDG-PET on lung cancer delineation for radiotherapy.
Morarji K; Fowler A; Vinod SK; Ho Shon I; Laurence JM
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):195-203. PubMed ID: 22498194
[TBL] [Abstract][Full Text] [Related]
19. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
[TBL] [Abstract][Full Text] [Related]
20. Inter-observer variability of organ contouring for preclinical studies with cone beam Computed Tomography imaging.
Lappas G; Staut N; Lieuwes NG; Biemans R; Wolfs CJA; van Hoof SJ; Dubois LJ; Verhaegen F
Phys Imaging Radiat Oncol; 2022 Jan; 21():11-17. PubMed ID: 35111981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
